Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease.

[1]  S. Hurd,et al.  Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update , 2003, European Respiratory Journal.

[2]  A. Buist.  Guidelines for the management of chronic obstructive pulmonary disease. , 2002, Respiratory medicine.

[3]  D. Mccrory,et al.  Management of acute exacerbations of COPD: a summary and appraisal of published evidence. , 2001, Chest.

[4]  M. Cazzola,et al.  Onset of action of single doses of formoterol administered via Turbuhaler in patients with stable COPD. , 2001, Pulmonary pharmacology & therapeutics.

[5]  R. Rodríguez-Roisín,et al.  Toward a consensus definition for COPD exacerbations. , 2000, Chest.

[6]  M. Cazzola,et al.  Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD. , 1998, The European respiratory journal.

[7]  M. Cazzola,et al.  The use of bronchodilators in stable chronic obstructive pulmonary disease. , 1997, Pulmonary pharmacology & therapeutics.

[8]  P. Barnes,et al.  Effect of short- and long-acting β2-adrenoceptor agonists on pulmonary β2-adrenoceptor expression in human lung , 1996 .

[9]  J C Yernault,et al.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.

[10]  M. Cazzola,et al.  Effect of salmeterol and formoterol in patients with chronic obstructive pulmonary disease. , 1994, Pulmonary pharmacology.

[11]  D. Postma,et al.  Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. , 1992, Thorax.

[12]  R. Pauwels,et al.  Time course of bronchodilating effect of inhaled formoterol, a potent and long acting sympathomimetic. , 1992, Thorax.

[13]  J. Karpel,et al.  A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD. , 1990, Chest.

[14]  M. Kenward,et al.  Design and Analysis of Cross-Over Trials , 1989 .

[15]  Buist As.  Standardization of spirometry. , 1987 .

[16]  V. Chew.  Testing Differences among Means: Correct Interpretation and Some Alternatives1 , 1980, HortScience.